{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"capn5-related-vitreoretinopathy","columns":[{"gene":"","key":"population-2266266279028e982134","label":"Vitreoretinopathy, neovascular inflammatory","mondoId":"MONDO:0100450","onsetQualifier":null,"originColumnKey":"MONDO:0100450/OMIM:193235","originalViews":[{"key":"MONDO:0100450/OMIM:193235","label":"Vitreoretinopathy, neovascular inflammatory","scopeLabel":"OMIM:193235","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["059a42a24aab84f1d46637e7f8dc70073ac6ca55a4581037e8d032db2da71103","08659d67d1ef2e424f69944ee9cc702d101be35aa7498bd155e4ab2f3d4816d6","196bacd4db9cee0a22b71727bca211710339ee7d20cd3b8151da4bb1b9b50108","1d7763b26b07d9175644fabe0a588e6e8eb2b70bb5fe46849db2fa9a7d1da5d0","21c7740b861d0545b1ea1944c31b4d1e0a427b8fc0a38d2c23fa4e9de41f5f0e","5e0148fca71b6eb1483ef0c43718ac7c1f9ce8d0f3beee7c0a4858291029eadc","6a183224e3fae78035f18cd637c3487c48830285da3b629b88d4ca2a39417276","8f47dbd33e1dd668d3ac39cf7449375f5423b8c767713bc921311577f818bb29","c7ddd173dabaf5da564127245213271df2ccfbc718bdb13643743632eb2cb01a"],"recordQualifiers":{},"scopeLabel":"OMIM:193235","sourceIds":["OMIM:193235"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-2266266279028e982134"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0000512","HP:0000618","HP:0007658","HP:0030667","HP:0007778","HP:0000541","HP:0000554"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":1,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":9,"sourceGroups":{"omim":9}},"features":[{"hpoId":"HP:0000512","label":"Abnormal electroretinogram","primary":true},{"hpoId":"HP:0000618","label":"Blindness","primary":true},{"hpoId":"HP:0007658","label":"Large hyperpigmented retinal spots","primary":true},{"hpoId":"HP:0030667","label":"Peripheral retinal neovascularization","primary":true},{"hpoId":"HP:0007778","label":"Posterior retinal neovascularization","primary":true},{"hpoId":"HP:0000541","label":"Retinal detachment","primary":true},{"hpoId":"HP:0000554","label":"Uveitis","primary":true},{"hpoId":"HP:0007773","label":"Vitreoretinopathy","primary":false},{"hpoId":"HP:0007902","label":"Vitreous hemorrhage","primary":false}],"ledeHtml":"A rare, genetic, vitreoretinal degeneration characterized by a slowly progressive vitreoretinopathy with onset during the second or third decade of life. The disease initially presents as autoimmune uveitis with reduction in the b-wave on electroretinography, and progresses with development of photoreceptor degeneration, vitreous hemorrhage, cystoid macular edema, retinal neovascularization, intraocular fibrosis, secondary glaucoma, and retinal detachment leading to phthisis and complete blindness.","mondoId":"MONDO:0100450","node":{"canonicalSlug":"capn5-related-vitreoretinopathy","comparisons":[{"documentSha256":"9f1aa17df4bd5f303287dde191aa52f2558a09d4aeb3a13e42f37b48b629eb78","key":"legacy-capn5-related-vitreoretinopathy","kind":"legacy","label":"CAPN5-related vitreoretinopathy","memberIds":["MONDO:0100450"],"mondoId":"MONDO:0100450","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/capn5-related-vitreoretinopathy.9f1aa17df4bd5f303287dde191aa52f2558a09d4aeb3a13e42f37b48b629eb78.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Autosomal dominant neovascular inflammatory vitreoretinopathy","originalSourceId":"ORPHA:329211","paragraphs":["A rare, genetic, vitreoretinal degeneration characterized by a slowly progressive vitreoretinopathy with onset during the second or third decade of life. The disease initially presents as autoimmune uveitis with reduction in the b-wave on electroretinography, and progresses with development of photoreceptor degeneration, vitreous hemorrhage, cystoid macular edema, retinal neovascularization, intraocular fibrosis, secondary glaucoma, and retinal detachment leading to phthisis and complete blindness."],"rawAttribution":"MONDO:0100450","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:02:34Z","upstream":"ORPHA:329211","url":"https://rarediseases.info.nih.gov/diseases/17497"},"ownColumnKeys":["population-2266266279028e982134"],"publication":"published","relationships":[{"kind":"parent","label":"vitreoretinal degeneration","mondoId":"MONDO:0020248","slug":null},{"kind":"parent","label":"proliferative vitreoretinopathy","mondoId":"MONDO:0700115","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"059a42a24aab84f1d46637e7f8dc70073ac6ca55a4581037e8d032db2da71103","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:193235","disease_name":"Vitreoretinopathy, neovascular inflammatory","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0007773","is_excluded":false,"label":"Vitreoretinopathy","onset_id":null,"reference":"OMIM:193235","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"08659d67d1ef2e424f69944ee9cc702d101be35aa7498bd155e4ab2f3d4816d6","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:193235","disease_name":"Vitreoretinopathy, neovascular inflammatory","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0007658","is_excluded":false,"label":"Large hyperpigmented retinal spots","onset_id":null,"reference":"OMIM:193235","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"196bacd4db9cee0a22b71727bca211710339ee7d20cd3b8151da4bb1b9b50108","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:193235","disease_name":"Vitreoretinopathy, neovascular inflammatory","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0030667","is_excluded":false,"label":"Peripheral retinal neovascularization","onset_id":null,"reference":"OMIM:193235","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"1d7763b26b07d9175644fabe0a588e6e8eb2b70bb5fe46849db2fa9a7d1da5d0","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:193235","disease_name":"Vitreoretinopathy, neovascular inflammatory","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000512","is_excluded":false,"label":"Abnormal electroretinogram","onset_id":null,"reference":"OMIM:193235","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"21c7740b861d0545b1ea1944c31b4d1e0a427b8fc0a38d2c23fa4e9de41f5f0e","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:193235","disease_name":"Vitreoretinopathy, neovascular inflammatory","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0007902","is_excluded":false,"label":"Vitreous hemorrhage","onset_id":null,"reference":"OMIM:193235","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"5e0148fca71b6eb1483ef0c43718ac7c1f9ce8d0f3beee7c0a4858291029eadc","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:193235","disease_name":"Vitreoretinopathy, neovascular inflammatory","evidence":"PCS","frequency_raw":"20/20","hpo_id":"HP:0000618","is_excluded":false,"label":"Blindness","onset_id":null,"reference":"OMIM:193235","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"6a183224e3fae78035f18cd637c3487c48830285da3b629b88d4ca2a39417276","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:193235","disease_name":"Vitreoretinopathy, neovascular inflammatory","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000541","is_excluded":false,"label":"Retinal detachment","onset_id":null,"reference":"OMIM:193235","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"8f47dbd33e1dd668d3ac39cf7449375f5423b8c767713bc921311577f818bb29","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:193235","disease_name":"Vitreoretinopathy, neovascular inflammatory","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0007778","is_excluded":false,"label":"Posterior retinal neovascularization","onset_id":null,"reference":"OMIM:193235","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"c7ddd173dabaf5da564127245213271df2ccfbc718bdb13643743632eb2cb01a","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:193235","disease_name":"Vitreoretinopathy, neovascular inflammatory","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000554","is_excluded":false,"label":"Uveitis","onset_id":null,"reference":"OMIM:193235","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17497\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0100450\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:329211</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare, genetic, vitreoretinal degeneration characterized by a slowly progressive vitreoretinopathy with onset during the second or third decade of life. The disease initially presents as autoimmune uveitis with reduction in the b-wave on electroretinography, and progresses with development of photoreceptor degeneration, vitreous hemorrhage, cystoid macular edema, retinal neovascularization, intraocular fibrosis, secondary glaucoma, and retinal detachment leading to phthisis and complete blindness.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17497\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"capn5-related-vitreoretinopathy","sourceDocuments":[{"name":"GARD: Autosomal dominant neovascular inflammatory vitreoretinopathy","reviewed":null,"source_release":"2026-10-21T17:02:34Z","url":"https://rarediseases.info.nih.gov/diseases/17497"},{"name":"MONDO: CAPN5-related vitreoretinopathy","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0100450"}],"sourceNote":"","synonyms":["ADNIV","autosomal dominant neovascular inflammatory vitreoretinopathy","CAPN5 vitreoretinopathy","retinitis proliferans","vitreoretinopathy, neovascular inflammatory","vitreoretinopathy, neovascular inflammatory, autosomal dominant","VRNI"],"takeawayHtml":"","title":"CAPN5-related vitreoretinopathy"},"schemaVersion":1}
